Another COVID-era “success story” on life supportRemember those biotech companies that soared during COVID? 💉💰
Imunon was one of them - riding the pandemic hype train all the way up. But just look at that chart now... 👀
From explosive highs to penny stock, it's now trading at $1.16, down 99.99% from its peak.
How many of these “COVID-era rocketships” are still worth holding? Or were they just pandemic pump-and-dumps dressed in hope and science?
